Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Hympavzi Approved in Europe for Severe Hemophilia A and B
The European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use (CHMP) recommended the granting of marketing authorization for Hympavzi (marstacimab) for treating bleeding episodes in people aged 12 years or older with severe hemophilia A and B. The…
English